Investors

Our Investors

Overview

MMC Laboratories is positioned at the forefront of the rapidly growing cannabis-derived pharmaceutical and wellness industry. With our fully compliant EU-standard manufacturing and cultivation facilities, we are uniquely equipped to meet increasing global demand for high-quality cannabis APIs and extracts.

We offer a strong investment opportunity grounded in:

  • Advanced technology and scalable production capacity
  • Strict adherence to international quality and compliance standards
  • A diverse product portfolio addressing both pharmaceutical and wellness markets
  • Sustainable cultivation practices with multiple annual harvests

As we continue to expand, we invite investors to join us in shaping the future of cannabis-based health solutions and capitalizing on a dynamic, evolving market.

MMC Laboratories at a Glance

API manufacturing in our EudraLex Volume 4 Part II compliant facility
Cultivation to Extraction on a single campus
EU-GaCP compliant cultivation
EU-GMP compliant processing
EU-GMP compliant APIs
CO2 Primary Extraction
Chromatographic isolation of cannabinoids
600 Kg monthly production
European stock holding
European batch release
European distribution

Get In Touch

P.O Box 2155, Lilongwe

+265 983329216

llw@mmclaboratories.com

https://www.mmclaboratories.mw/